DE69430626T2 - Neue phospholipid-saccharid-konjugate - Google Patents

Neue phospholipid-saccharid-konjugate

Info

Publication number
DE69430626T2
DE69430626T2 DE69430626T DE69430626T DE69430626T2 DE 69430626 T2 DE69430626 T2 DE 69430626T2 DE 69430626 T DE69430626 T DE 69430626T DE 69430626 T DE69430626 T DE 69430626T DE 69430626 T2 DE69430626 T2 DE 69430626T2
Authority
DE
Germany
Prior art keywords
conjugates
saccharid
phospholipid
new phospholipid
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69430626T
Other languages
English (en)
Other versions
DE69430626D1 (de
Inventor
Y Wan
M Staveski
E Walts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of DE69430626D1 publication Critical patent/DE69430626D1/de
Publication of DE69430626T2 publication Critical patent/DE69430626T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE69430626T 1993-03-12 1994-03-09 Neue phospholipid-saccharid-konjugate Expired - Fee Related DE69430626T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/030,793 US5354853A (en) 1993-03-12 1993-03-12 Phospholipid-saccharide conjugates
PCT/US1994/002535 WO1994021656A2 (en) 1993-03-12 1994-03-09 Novel phospholipid-saccharide conjugates

Publications (2)

Publication Number Publication Date
DE69430626D1 DE69430626D1 (de) 2002-06-20
DE69430626T2 true DE69430626T2 (de) 2002-12-19

Family

ID=21856073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430626T Expired - Fee Related DE69430626T2 (de) 1993-03-12 1994-03-09 Neue phospholipid-saccharid-konjugate

Country Status (7)

Country Link
US (1) US5354853A (de)
EP (1) EP0688329B1 (de)
JP (1) JPH08507544A (de)
AT (1) ATE217631T1 (de)
CA (1) CA2158055A1 (de)
DE (1) DE69430626T2 (de)
WO (1) WO1994021656A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10207177A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
DE102004038443A1 (de) * 2004-08-07 2006-03-16 Bioghurt Biogarde Gmbh & Co. Kg Verfahren zur enzymatischen Herstellung und/oder Modifikation von Phospholipiden

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11511128A (ja) * 1995-08-01 1999-09-28 ノバルティス・アクチエンゲゼルシャフト リポソームオリゴヌクレオチド組成物
AU5571196A (en) * 1996-04-24 1997-11-12 Sdg, Inc. Improved masking of liposomes from res recognition
PT939647E (pt) * 1996-08-27 2002-04-29 Chiron Corp Glicpconjugados do serogrupo b de neisseria meningitidis e metodos de utilizacao dos mesmos
US6071532A (en) * 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US6204254B1 (en) 1997-09-12 2001-03-20 Baxter International, Inc. Biocompatible surfaces and a method for their preparation
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
JP3861133B2 (ja) * 1999-12-07 2006-12-20 独立行政法人産業技術総合研究所 グルコシルフォスファチジルグリセロール誘導体の製造方法
US8501701B2 (en) * 2000-01-10 2013-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
US8076312B2 (en) * 2000-01-10 2011-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Use of lipid conjugates in the treatment of disease
US7893226B2 (en) 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US20090325876A1 (en) * 2004-09-29 2009-12-31 Saul Yedgar Use of lipid conjugates in the treatment of diseases associated with vasculature
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US20060189570A1 (en) * 2000-01-10 2006-08-24 Saul Yedgar Use of lipid conjugates in the treatment of infection
US9040078B2 (en) 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
US8304395B2 (en) * 2000-01-10 2012-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid conjugates in the treatment of disease
US7772196B2 (en) * 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US7811999B2 (en) 2000-01-10 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US7393938B2 (en) * 2000-01-10 2008-07-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US6749865B2 (en) * 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
AU2001238346A1 (en) 2000-02-15 2001-08-27 Genzyme Corporation Modification of biopolymers for improved drug delivery
DE50115872D1 (de) * 2000-12-06 2011-06-16 Ecole Polytech Verfahren zur herstellung eines bioanalytischen reagenzes, nachweisverfahren beruhend auf der verwendung des bioanalytischen reagenz, sowie dessen verwendung
US8883761B2 (en) * 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
US20050013810A1 (en) * 2001-05-08 2005-01-20 Waller Edmund K Regulating immune response using dendritic cells
US20060193906A1 (en) * 2002-01-30 2006-08-31 National Institute Of Advanced Industrial Science And Technology Sugar-modified liposome and products comprising the liposome
US7070801B2 (en) * 2002-01-30 2006-07-04 National Institute Of Advanced Industrial Science And Technology Sugar-modified liposome and products comprising the liposome
US7299805B2 (en) * 2002-06-07 2007-11-27 Marctec, Llc Scaffold and method for implanting cells
US20040131631A1 (en) * 2002-11-22 2004-07-08 Alexander Andrianov Polyphosphazene immunostimulants
ATE389731T1 (de) * 2002-12-12 2008-04-15 Novozymes As Verfahren zur auswahl eines lipolytischen enzyms
WO2005011632A1 (ja) * 2003-08-01 2005-02-10 National Institute Of Advanced Industrial Science And Technology 糖鎖を有する標的指向性および腸管吸収制御性リポソームならびにそれを含む癌治療薬および診断薬
WO2005049631A1 (en) * 2003-11-18 2005-06-02 The Malaghan Institute Of Medical Research Synthetic molecules having immune activity
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
CN104546891A (zh) * 2005-08-03 2015-04-29 塞尔索斯治疗公司 脂质结合物在囊性纤维化病中的用途及其应用
JP4744973B2 (ja) * 2005-08-05 2011-08-10 株式会社トプコン 眼底カメラ
US8859524B2 (en) 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
US20110130555A1 (en) 2009-05-11 2011-06-02 Saul Yedgar Lipid-polymer conjugates, their preparation and uses thereof
US8906882B2 (en) 2005-11-17 2014-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of allergic rhinitis
US20080183282A1 (en) * 2006-03-09 2008-07-31 Saul Yedgar Use of lipid conjugates for the coating of stents and catheters
CA2705785A1 (en) * 2006-11-14 2008-05-22 Saul Yedgar Use of lipid conjugates in the treatment of diseases or disorders of the eye
KR100829595B1 (ko) 2006-12-11 2008-05-14 한국화학연구원 당이 결합된 인지질로 수식된 리포솜 및 이의 제조방법
WO2013035757A1 (ja) * 2011-09-07 2013-03-14 国立大学法人京都大学 6炭糖-6-リン酸修飾コレステロール誘導体含有製剤
EP3059236A1 (de) * 2015-02-23 2016-08-24 Abivax Neue Chinolinderivate zur Verwendung bei der Behandlung und Prävention von Virusinfektionen
EP3058940A1 (de) * 2015-02-23 2016-08-24 Abivax Chinolin-Derivate zur Behandlung oder Vorbeugung von viralen Infektionen
CN105153251B (zh) * 2015-09-29 2018-03-20 浙江合糖科技有限公司 一种单糖甲苷的苄基化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585762A (en) * 1982-07-30 1986-04-29 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, processes for use thereof and pharmaceutical composition of the same
JPS59187792A (ja) * 1983-04-11 1984-10-24 Meito Sangyo Kk 酵素法リン脂質糖類誘導体の製法
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
FR2596651B1 (fr) * 1986-04-08 1989-11-10 Centre Nat Rech Scient Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
WO1989008499A1 (en) * 1988-03-17 1989-09-21 Nippon Fine Chemical Co., Ltd. Liposome
GB8825290D0 (en) * 1988-10-28 1988-11-30 Hounsell E F Characterisation of glycoproteins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10207177A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
DE102004038443A1 (de) * 2004-08-07 2006-03-16 Bioghurt Biogarde Gmbh & Co. Kg Verfahren zur enzymatischen Herstellung und/oder Modifikation von Phospholipiden

Also Published As

Publication number Publication date
US5354853A (en) 1994-10-11
CA2158055A1 (en) 1994-09-29
EP0688329A1 (de) 1995-12-27
WO1994021656A2 (en) 1994-09-29
JPH08507544A (ja) 1996-08-13
EP0688329B1 (de) 2002-05-15
WO1994021656A3 (en) 1994-11-10
DE69430626D1 (de) 2002-06-20
ATE217631T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
DE69430626D1 (de) Neue phospholipid-saccharid-konjugate
DK49390A (da) Makrocykliske, bifunktionelle chelanter, komplekser deraf og deres antistofkonjugater
HN1997000012A (es) Derivados de triazol utiles en terapia.
FI900147A0 (fi) Daempningsanordning foer stoetbelastning.
BR8903338A (pt) Barra de detergente translucida
AU581144B2 (en) Toilet compositions
DE69424245T2 (de) Differential-Gehäuse
DE69232875T2 (de) MHC-Konjugate zur Verbesserung der Autoimmunität.
BR9205969A (pt) Novas toxinas ativas contra nematóides e genes que codificam as mesmas
DE68919366D1 (de) Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.
DE69404837D1 (de) Elektromechanisches klavier
DE58902491D1 (de) Neue difluormethyl-thiadiazolyl-oxyessigsaeureamiden.
FR2705907B1 (fr) Perfectionnements apportés aux poupées.
DE4497279T1 (de) Klavier
FR2779147B1 (fr) Derive de thiocolchicoside sa preparation et son application en therapeutique
ATA81694A (de) Ortsveränderbare von wasser getragene veranstaltungseinrichtung
DK0400845T3 (da) Forbedringer vedrørende gasbrændere
GB9308991D0 (en) Improvements in or relating to sound source location
ATE99919T1 (de) Hydrolysebestaendige vinyl-lactam-amino-acrylamid- polymere.
ITMI922688A1 (it) Sistema per il trattamento della pelle
KR880000620A (ko) 조작 패널의 표면처리 방법
ITFE930013U1 (it) Bacchette orientali meccanizzate.
KR940023610U (ko) 조립이 용이한 잭
ITPD930181A1 (it) Struttura abitativa modulare componibile per campeggi o simili
KR970011476U (ko) 무선호출기를 휴대폰에 내장 또는 부착

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee